{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:14:52Z","timestamp":1769721292746,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1259,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41379-019-0264-2","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T12:04:01Z","timestamp":1554465841000},"page":"1135-1146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases"],"prefix":"10.1016","volume":"32","author":[{"given":"Akira","family":"Satou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-3725","authenticated-orcid":false,"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4855-4366","authenticated-orcid":false,"given":"Toyonori","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-019-0264-2_bib1","first-page":"S52","article-title":"Drug combinations with methotrexate to treat rheumatoid arthritis","volume":"28","author":"Rath","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/s41379-019-0264-2_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archinternmed.2007.107","article-title":"Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis","volume":"168","author":"Bernatsky","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1038\/s41379-019-0264-2_bib3","unstructured":"Gaulard P, Swerdlow SH, Harris NL, et al. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, et al. editors. World Health Organization classification of tumours of hematopoietic and lymphoid tissue. Revised 4th edn. Lyon, France: International Agency of Research on Cancer; 2017. p. 462\u20134."},{"key":"10.1038\/s41379-019-0264-2_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions","volume":"88","author":"Thomas","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-019-0264-2_bib5","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk","volume":"32a","author":"Mellemkjaer","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-019-0264-2_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","article-title":"Incidence of cancer among patients with rheumatoid arthritis","volume":"85","author":"Gridley","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-019-0264-2_bib7","first-page":"322","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1038\/s41379-019-0264-2_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1038\/s41379-019-0264-2_bib9","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"Mariette","year":"2002","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0264-2_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3899\/jrheum.130270","article-title":"A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders","volume":"41","author":"Yamakawa","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1038\/s41379-019-0264-2_bib11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/cas.13249","article-title":"Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: Comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types","volume":"108","author":"Gion","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1038\/s41379-019-0264-2_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prp.2009.03.005","article-title":"Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma","volume":"206","author":"Hatanaka","year":"2010","journal-title":"Pathol Res Pract"},{"key":"10.1038\/s41379-019-0264-2_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1684\/ejd.2015.2582","article-title":"Methotrexate-associated lymphoproliferative disorder: Sequential development of angioimmunoblastic T-cell lymphoma-like lymphoproliferation in the lymph nodes and diffuse large B-cell lymphoma in the skin in the same patient","volume":"25","author":"Ishibuchi","year":"2015","journal-title":"Eur J Dermatol"},{"key":"10.1038\/s41379-019-0264-2_bib14","first-page":"1","article-title":"Methotrexate-associated primary cutaneous CD30-positive cutaneous T-cell lymphoproliferative disorder: a case illustration and a brief review","volume":"6","author":"Claudino","year":"2016","journal-title":"Am J Blood Res"},{"key":"10.1038\/s41379-019-0264-2_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jdcr.2016.02.002","article-title":"Methotrexate-induced CD30(+) T-cell lymphoproliferative disorder of the oral cavity","volume":"2","author":"Saleh","year":"2016","journal-title":"JAAD Case Rep"},{"key":"10.1038\/s41379-019-0264-2_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12185-010-0642-5","article-title":"Epstein-Barr virus-infected subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment","volume":"92","author":"Nemoto","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1038\/s41379-019-0264-2_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/14397595.2013.850613","article-title":"CD8-positive T-cell lymphoproliferative disorder associated with Epstein-Barr virus-infected B-cells in a rheumatoid arthritis patient under methotrexate treatment","volume":"26","author":"Koji","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1038\/s41379-019-0264-2_bib18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3109\/s10165-010-0300-z","article-title":"CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy","volume":"20","author":"Hatachi","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1038\/s41379-019-0264-2_bib19","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2169\/internalmedicine.0308-17","article-title":"Adult T-cell leukemia\/lymphoma as a methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis","volume":"57","author":"Takajo","year":"2018","journal-title":"Intern Med"},{"key":"10.1038\/s41379-019-0264-2_bib20","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2011-08-374371","article-title":"Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan","volume":"119","author":"Tokunaga","year":"2012","journal-title":"Blood"},{"key":"10.1038\/s41379-019-0264-2_bib21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.pas.0000173238.17331.6b","article-title":"Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified","volume":"29","author":"Asano","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0264-2_bib22","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1038\/s41379-019-0264-2_bib23","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","article-title":"Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression","volume":"31","author":"Attygalle","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0264-2_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.2007.06725.x","article-title":"Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases","volume":"138","author":"Willenbrock","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1038\/s41379-019-0264-2_bib25","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/jnci\/djh313","article-title":"Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas","volume":"96","author":"Feng","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-019-0264-2_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1387\/ijdb.041947el","article-title":"The human T cell immune response to Epstein-Barr virus","volume":"49","author":"Landais","year":"2005","journal-title":"Int J Dev Biol"},{"key":"10.1038\/s41379-019-0264-2_bib27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/10428190701245138","article-title":"Angioimmunoblastic T-cell lymphoma: immune modulation as a therapeutic strategy","volume":"48","author":"Dunleavy","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/s41379-019-0264-2_bib28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MOH.0b013e328186ffbf","article-title":"Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications","volume":"14","author":"Dunleavy","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/s41379-019-0264-2_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0966-842X(94)90599-1","article-title":"Epstein-Barr virus: adaptation to a life within the immune system","volume":"2","author":"Masucci","year":"1994","journal-title":"Trends Microbiol"},{"key":"10.1038\/s41379-019-0264-2_bib30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nm0896-906","article-title":"Large clonal expansions of CD8+ T cells in acute infectious mononucleosis","volume":"2","author":"Callan","year":"1996","journal-title":"Nat Med"},{"key":"10.1038\/s41379-019-0264-2_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10067-018-4011-8","article-title":"Methotrexate preferentially affects Tc1 and Tc17 subset of CD8 T lymphocytes","volume":"38","author":"Sandhu","year":"2019","journal-title":"Clinical Rheumatol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0264-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0264-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222010304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222010304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0264-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:44:12Z","timestamp":1760229852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222010304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0893395222010304"],"URL":"https:\/\/doi.org\/10.1038\/s41379-019-0264-2","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-019-0264-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}